Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Yu, Jeong Jin
2015.
Use of corticosteroids during acute phase of Kawasaki disease.
World Journal of Clinical Pediatrics,
Vol. 4,
Issue. 4,
p.
135.
Zhang, Chang’e
Wang, Wenju
Zhang, Hong’e
Wei, Lulu
and
Guo, Shuping
2016.
Association ofFCGR2Ars1801274 polymorphism with susceptibility to autoimmune diseases: A meta-analysis.
Oncotarget,
Vol. 7,
Issue. 26,
p.
39436.
Yoo, Byung Won
2019.
New Insight to the Pathogenetic Mechanism of Kawasaki Disease (KD): the Relationship between Clinical Diversity and Genetic Heterogeneity.
Korean Circulation Journal,
Vol. 49,
Issue. 1,
p.
109.
Nagelkerke, Sietse Q.
Tacke, Carline E.
Breunis, Willemijn B.
Tanck, Michael W. T.
Geissler, Judy
Png, Eileen
Hoang, Long T.
van der Heijden, Joris
Naim, Ahmad N. M.
Yeung, Rae S. M.
Levin, Michael L.
Wright, Victoria J.
Burgner, David P.
Ponsonby, Anne-Louise
Ellis, Justine A.
Cimaz, Rolando
Shimizu, Chisato
Burns, Jane C.
Fijnvandraat, Karin
van der Schoot, C. Ellen
van den Berg, Timo K.
de Boer, Martin
Davila, Sonia
Hibberd, Martin L.
and
Kuijpers, Taco W.
2019.
Extensive Ethnic Variation and Linkage Disequilibrium at the FCGR2/3 Locus: Different Genetic Associations Revealed in Kawasaki Disease.
Frontiers in Immunology,
Vol. 10,
Issue. ,
Tang, Bin
Lo, Hang Hong
Lei, Cheng
U, Ka In
Hsiao, Wen-Luan Wendy
Guo, Xiaoling
Bai, Jun
Wong, Vincent Kam-Wai
and
Law, Betty Yuen-Kwan
2020.
Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.
Phytomedicine,
Vol. 70,
Issue. ,
p.
153208.
Wang, Zhiyong
and
Geng, Pei-Liang
2020.
CD32a
polymorphism rs1801274 affects the risk of Kawasaki disease
.
Artificial Cells, Nanomedicine, and Biotechnology,
Vol. 48,
Issue. 1,
p.
620.
Kumrah, Rajni
Vignesh, Pandiarajan
Rawat, Amit
and
Singh, Surjit
2020.
Immunogenetics of Kawasaki disease.
Clinical Reviews in Allergy & Immunology,
Vol. 59,
Issue. 1,
p.
122.
Kozak, Kateryna
Pavlyshyn, Halyna
Kamyshnyi, Oleksandr
Shevchuk, Oksana
Korda, Mykhaylo
and
Vari, Sandor G.
2023.
The Relationship between COVID-19 Severity in Children and Immunoregulatory Gene Polymorphism.
Viruses,
Vol. 15,
Issue. 10,
p.
2093.
Uittenbogaard, Paula
Netea, Stejara A.
Tanck, Michael W. T.
Geissler, Judy
Buda, Piotr
Kowalczyk-Domagała, Monika
Okarska-Napierała, Magdalena
van Stijn, Diana
Tacke, Carline E.
Burgner, David P.
Shimizu, Chisato
Burns, Jane C.
Kuipers, Irene M.
Kuijpers, Taco W.
and
Nagelkerke, Sietse Q.
2024.
FCGR2/3 polymorphisms are associated with susceptibility to Kawasaki disease but do not predict intravenous immunoglobulin resistance and coronary artery aneurysms.
Frontiers in Immunology,
Vol. 15,
Issue. ,
Yeşiltepe, Esra
Duman, Derya
Kuyucu, Necdet
Bozdoğan, Sevcan Tuğ
Çıtırık, Lara
Yeşil, Edanur
and
Karpuz, Derya
2025.
FCGR2A Gene Polymorphism Association in Children with Multisystem Inflammatory Syndrome.
Indian Pediatrics,
Vol. 62,
Issue. 5,
p.
372.
Goyal, Taru
Sharma, Saniya
Pilania, Rakesh Kumar
Jawallia, Kajol
Chawla, Sanchi
Sharma, Madhubala
Rawat, Monica
Thakur, Vaishali
Arya, Urvi
Kumar, Anoop
Dhaliwal, Manpreet
Pandiarajan, Vignesh
Rawat, Amit
and
Singh, Surjit
2025.
Genetic Landscape of Kawasaki Disease: An Update.
Lymphatics,
Vol. 3,
Issue. 3,
p.
21.